Investigational Drug Service: Maintaining Consistency in a Dynamic Field
Release date: March 20, 2019
Expiration date: March 20, 2022
ACPE credit must be claimed by: March 20, 2022
Offered On-Demand only.
This webinar is also part of the 2019 ACPE Webinar Bundle
Pharmaceutical companies and their investigational products can be expected to change with relative frequency. Investigational pharmacies should prepare for this change and develop strategies to manage it efficiently. This presentation will discuss strategies to maintain standard practices that facilitate reproducible, accurate results in an evolving system.
- Describe the importance of streamlining and standardization of operations and procedures.
- Explore alternatives to traditional protocol binders.
- Examine the fundamentals of a successful IDS workforce.
Krista Wolf, PharmD
Supervisor, Investigational Drug Service at Oregon Health and Science University
Krista Wolf received a Bachelor of Science in molecular cellular biology from the University of Illinois at Urbana-Champaign in 2005 and a PharmD degree from the University of Illinois at Chicago in 2010. She subsequently completed a PGY-1 pharmacy practice residency at the University of Illinois at Chicago. She began work as an Investigational Drug Service pharmacist in 2012 at the University of Colorado Hospital Anschutz Cancer Pavilion. In 2015 she became supervisor of the Investigational Drug Service at Oregon Health and Science University.
This activity is intended for Hematology/Oncology pharmacists. This activity has been approved for 1.00 contact hours (.10CEUs) under the ACPE universal activity number # 0465-0000-19-055-H04-P.
HOPA Member ‒ $20
Nonmember ‒ $40
The Hematology/Oncology Pharmacy Association (HOPA) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. A statement of credit will be issued only upon completion of the post-activity evaluation form and post-test. ACPE credit must be claimed by March 20,k 2022.
Disclosure of Conflicts of Interest: The Hematology/Oncology Pharmacy Association (HOPA) assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CE activities. All relevant conflicts of interest that are identified are thoroughly vetted by HOPA for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. HOPA is committed to providing its learners with high-quality CE activities and related materials that promote improvements of quality in healthcare and not a specific proprietary business interest of a commercial interest.